Haryana, India

Radhakrishnan Gowri Shankar


Average Co-Inventor Count = 5.0

ph-index = 1


Location History:

  • Gurgaon, IN (2005)
  • Haryana, IN (2006)

Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Radhakrishnan Gowri Shankar: Innovator in Pharmaceutical Chemistry

Introduction

Radhakrishnan Gowri Shankar is a notable inventor based in Haryana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 2 patents to his name, his work has had a meaningful impact on medical treatments.

Latest Patents

His latest patents include a Tamsulosin derivative, specifically the optically active compound, R (−)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-hydroxybenzenesulfonamide. This compound is recognized for its good optical purity and serves as a metabolite of the α-adrenergic blocking agent tamsulosin. The patents also detail methods for the preparation of this compound, as well as pharmaceutical compositions that include the optically active compound. These compositions are designed for methods of treatment that involve the administration of an effective α-adrenergic antagonistic amount to mammals.

Career Highlights

Radhakrishnan has worked with prominent companies in the pharmaceutical industry, including Ranbaxy Laboratory Limited and Ranbaxy Laboratories, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Radhakrishnan has collaborated with several professionals in the field. Notable coworkers include Yatendra Kumar and Ram Chander Aryan, who have contributed to various projects alongside him.

Conclusion

Radhakrishnan Gowri Shankar's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…